• About us
• Contact

Advertisement

Organisation › Details

Sartorius Stedim Biotech GmbH (SSB)

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2021, the company employed more than 10,400 people, and earned sales revenue of around 2.89 billion euros. *

 

	Start	2008-10-31 existent
	Group	Sartorius (Group)
	Industry	laboratory equipment and instruments
	Industry 2	BIOTECH
	Region	Göttingen
	Country	Germany
	Street	11 August-Spindler-Str.
	City	37079 Göttingen
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2022-06-30)
	Currency	EUR
	Annual sales	2,890,000,000 (sales revenue, group (2021) 2021-12-31)
		* Document for »About Section«: Sartorius Stedim Biotech S.A.. (7/21/22). "Press Release: Half-year Results 2022 of Sartorius Stedim Biotech. Sales Revenue up 22.1 Percent in Constant Currencies, Underlying EBITDA Margin 35.2 Percent ". Aubagne.
		Record changed: 2025-07-06

Advertisement

More documents for Sartorius (Group)

• [1] Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen....
• [2] Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen....
• [3] Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam....
• [4] Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford....
• [5] Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen....
• [6] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
• [7] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
• [8] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
• [9] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
• [10] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.